Showing results (1141-1150 of 2,319) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|December 8, 2020
HSP47: a potential target for fibrotic diseases and implications for therapyPierre-Simon Bellaye, Olivier Burgy, Philippe Bonniaud, et al.Expert Opinion on Therapeutic Targets|October 5, 2020
Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Paola Boggione, Abdurraouf Mokhtar Mahmoud, et al.Expert Opinion on Therapeutic Targets|October 9, 2020
Systemic lupus erythematosus (SLE): emerging therapeutic targetsLauren M Mathias, William StohlExpert Opinion on Therapeutic Targets|October 6, 2020
Emerging therapeutic targets for neuroblastomaNatarajan Aravindan, Terence Herman, Sheeja AravindanExpert Opinion on Therapeutic Targets|December 23, 2022
Beyond basic research: the contribution of cathepsin B to cancer development, diagnosis and therapyAndrey A Zamyatnin, Levy C Gregory, Paul A Townsend, et al.Expert Opinion on Therapeutic Targets|June 25, 2021
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromesEdward Richardson, David García-Bernal, Eleonora Calabretta, et al.Expert Opinion on Therapeutic Targets|December 21, 2022
Granzyme B as a therapeutic target: an update in 2022Alexandre Aubert, Michael Lane, Karen Jung, et al.Expert Opinion on Therapeutic Targets|December 5, 2022
Dyskinesia and Parkinson's disease: animal model, drug targets, and agents in preclinical testingValentina Cesaroni, Fabio Blandini, Silvia CerriExpert Opinion on Therapeutic Targets|October 8, 2010
TGF-β: friend or foe? The role of TGF-β/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapyJian-Liang Chou, Lin-Yu Chen, Hung-Cheng Lai, et al.Expert Opinion on Therapeutic Targets|October 15, 2010
Targeting oxidative stress in cancerMatthew W Lawless, Kenneth J O'Byrne, Steven G GrayPageof 232